TR200401775T4 - 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri - Google Patents

3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri

Info

Publication number
TR200401775T4
TR200401775T4 TR2004/01775T TR200401775T TR200401775T4 TR 200401775 T4 TR200401775 T4 TR 200401775T4 TR 2004/01775 T TR2004/01775 T TR 2004/01775T TR 200401775 T TR200401775 T TR 200401775T TR 200401775 T4 TR200401775 T4 TR 200401775T4
Authority
TR
Turkey
Prior art keywords
amino
triazole
phenyl
pharmaceutical compositions
manufacture
Prior art date
Application number
TR2004/01775T
Other languages
English (en)
Turkish (tr)
Inventor
Gully Danielle
Pierre Maffrand Jean
Geslin Michel
Roger Pierre
Original Assignee
Sanofi - Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Synthelabo filed Critical Sanofi - Synthelabo
Publication of TR200401775T4 publication Critical patent/TR200401775T4/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2004/01775T 1999-12-17 2000-12-14 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri TR200401775T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
TR200401775T4 true TR200401775T4 (tr) 2004-09-21

Family

ID=9553380

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2004/01775T TR200401775T4 (tr) 1999-12-17 2000-12-14 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
TR2002/01600T TR200201600T2 (tr) 1999-12-17 2000-12-14 Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2002/01600T TR200201600T2 (tr) 1999-12-17 2000-12-14 Yer-alıma tabi tutulan, yeni, dallı 3-amino-1-fenil-1H-[1,2,4]triazol amino türevleri, bunların hazırlanması için prosesler ve bunları içeren farmasötik kompozisyonlar.

Country Status (33)

Country Link
US (1) US6806282B2 (https=)
EP (1) EP1242389B1 (https=)
JP (1) JP4146641B2 (https=)
KR (1) KR100705525B1 (https=)
CN (1) CN1293061C (https=)
AR (1) AR031837A1 (https=)
AT (1) ATE264847T1 (https=)
AU (1) AU780711B2 (https=)
BR (1) BR0017023A (https=)
CA (1) CA2398772C (https=)
CO (1) CO5251379A1 (https=)
CZ (1) CZ302460B6 (https=)
DE (1) DE60010126T2 (https=)
DK (1) DK1242389T3 (https=)
EA (1) EA004957B1 (https=)
EE (1) EE04778B1 (https=)
ES (1) ES2219436T3 (https=)
FR (1) FR2802530B1 (https=)
HU (1) HUP0204080A3 (https=)
IL (2) IL150037A0 (https=)
IS (1) IS2315B (https=)
ME (1) MEP12108A (https=)
MX (1) MXPA02006033A (https=)
NO (1) NO20022828L (https=)
PL (1) PL203819B1 (https=)
PT (1) PT1242389E (https=)
RS (1) RS50289B (https=)
SK (1) SK285994B6 (https=)
TR (2) TR200401775T4 (https=)
TW (1) TWI289554B (https=)
UA (1) UA73333C2 (https=)
WO (1) WO2001044207A2 (https=)
ZA (1) ZA200204422B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013982A1 (en) * 2003-08-06 2005-02-17 Vertex Pharmaceuticals Incorporated Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
JP2011500625A (ja) 2007-10-18 2011-01-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ トリ置換された１，２，４−トリアゾール
AR070936A1 (es) 2008-03-19 2010-05-12 Janssen Pharmaceutica Nv 1,2,4 -triazoles trisustituidos
JP5486591B2 (ja) 2008-05-09 2014-05-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アセチルコリン受容体モジュレーターとしての三置換ピラゾール
EP2629616A4 (en) * 2010-10-21 2014-03-26 Merck Sharp & Dohme SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
WO2015112642A1 (en) 2014-01-21 2015-07-30 Neurocrine Biosciences, Inc. Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
CA3121920A1 (en) 2018-12-07 2020-06-11 Neurocrine Biosciences, Inc. Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
IL291569B2 (en) * 2019-09-25 2025-04-01 Oncoarendi Therapeutics Sa Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-4,2,1-triazol-3-amine
JP7623365B2 (ja) 2019-09-27 2025-01-28 ニューロクライン バイオサイエンシーズ，インコーポレイテッド Ｃｒｆ受容体アンタゴニストおよび使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285893B1 (en) * 1987-03-27 1992-03-18 Kumiai Chemical Industry Co., Ltd. Phenyltriazole derivative and insecticide
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
KR100705525B1 (ko) 2007-04-10
EA200200523A1 (ru) 2002-12-26
WO2001044207B1 (fr) 2002-06-06
CN1434808A (zh) 2003-08-06
FR2802530B1 (fr) 2002-02-22
TR200201600T2 (tr) 2002-10-21
DK1242389T3 (da) 2004-08-09
AR031837A1 (es) 2003-10-08
KR20020061002A (ko) 2002-07-19
ES2219436T3 (es) 2004-12-01
WO2001044207A3 (fr) 2001-12-20
CA2398772C (fr) 2011-07-05
SK8502002A3 (en) 2003-02-04
CZ20022099A3 (cs) 2002-09-11
CZ302460B6 (cs) 2011-06-01
EE200200331A (et) 2003-06-16
FR2802530A1 (fr) 2001-06-22
ATE264847T1 (de) 2004-05-15
CO5251379A1 (es) 2003-02-28
EP1242389B1 (fr) 2004-04-21
EA004957B1 (ru) 2004-10-28
RS50289B (sr) 2009-09-08
WO2001044207A2 (fr) 2001-06-21
HK1055947A1 (en) 2004-01-30
ZA200204422B (en) 2003-11-26
HUP0204080A3 (en) 2005-01-28
MEP12108A (en) 2010-06-10
PL355811A1 (en) 2004-05-17
AU780711B2 (en) 2005-04-14
UA73333C2 (en) 2005-07-15
NO20022828L (no) 2002-08-19
CA2398772A1 (fr) 2001-06-21
SK285994B6 (sk) 2008-01-07
JP2003516975A (ja) 2003-05-20
YU43902A (sh) 2005-03-15
EP1242389A2 (fr) 2002-09-25
JP4146641B2 (ja) 2008-09-10
AU2525901A (en) 2001-06-25
HUP0204080A2 (hu) 2003-04-28
PT1242389E (pt) 2004-08-31
IS2315B (is) 2007-11-15
IS6402A (is) 2002-05-28
IL150037A0 (en) 2002-12-01
NO20022828D0 (no) 2002-06-13
TWI289554B (en) 2007-11-11
EE04778B1 (et) 2007-02-15
MXPA02006033A (es) 2003-01-28
US6806282B2 (en) 2004-10-19
BR0017023A (pt) 2002-12-03
DE60010126T2 (de) 2005-04-28
DE60010126D1 (de) 2004-05-27
WO2001044207A8 (fr) 2001-07-12
US20030162771A1 (en) 2003-08-28
PL203819B1 (pl) 2009-11-30
CN1293061C (zh) 2007-01-03
IL150037A (en) 2007-02-11

Similar Documents

Publication Publication Date Title
MX9605665A (es) Bis (resorcinil) triazinas.
CA2216535A1 (en) Protein kinase c inhibitors
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
CA2137203A1 (en) Protein kinase c inhibitors
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
CA2237221A1 (en) Protein kinase c inhibitor
AU4666996A (en) Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
BG103947A (en) Derivatives of 9-oxymerythromycin
MY115211A (en) Novel amino acid derivatives, their preparation and use
TR199901433T2 (xx) Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
WO2000039083A3 (en) Pyrazole compounds and uses thereof
TR200401775T4 (tr) 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
HUP9901190A3 (en) Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
MY125854A (en) Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide
AU6633596A (en) Improved therapeutic agents
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
CA2195747A1 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them
TR199900013T2 (xx) Yeni bile�ikler.
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
ATE211489T1 (de) Chitosan enthaltende zusammensetzung